ReShape Lifesciences (HIND) Earnings (2015 - 2026)
ReShape Lifesciences (HIND) earnings from Sep 30, 2015 to Mar 31, 2026. The TTM ReShape Lifesciences (HIND) earnings is -$11M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
ReShape Lifesciences (HIND) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -35.53% |
| 5 Years TTM | -12.46% |
| 10 Years TTM | +4.34% |
| All Time TTM | -1.80% |
Annual Earnings change of ReShape Lifesciences (HIND)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$960K | -90.64% |
| 2025 | -$10M | +607.59% |
| 2024 | -$1.45M | -87.27% |
| 2023 | -$11M | -75.35% |
| 2022 | -$46M | -26.83% |
| 2021 | -$63M | +191.96% |
| 2020 | -$22M | -8.66% |
| 2019 | -$24M | -36.65% |
| 2018 | -$37M | +7.54% |
| 2017 | -$35M | +69.81% |
| 2016 | -$20M | +31.56% |
| 2015 | -$16M | +57.33% |
| 2014 | -$9.89M | N/A |
Comparison ReShape Lifesciences (HIND) five years earnings CAGR with competitors
ReShape Lifesciences (HIND) five years earnings CAGR is -12.44%.